Comparison of innate lymphoid cells from tissue and blood in chronic tonsillitis and tonsillar hypertrophy.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 12 07 2023
revised: 28 08 2023
accepted: 18 09 2023
medline: 23 10 2023
pubmed: 25 9 2023
entrez: 24 9 2023
Statut: ppublish

Résumé

Recurrent tonsillitis and tonsillar hypertrophy are two common diseases in children for which tonsillectomy is the definitive solution. The underlying causes of both diseases are not fully known. The aim of this study was to identify the predominant innate lymphoid cells in both diseases of the palatine tonsils, which are known to play an important role in the immune system. Children who underwent tonsillectomy were divided into two groups as recurrent tonsillitis and tonsillar hypertrophy according to the indication for surgery. The proportions of innate lymphoid cell (ILC) groups and IFN-gamma, IL-10 and IL-17 secreting T lymphocyte cells were determined in tonsil and blood samples obtained during surgery. Local and peripheral immune responses were evaluated. Innate immune responses and acquired immune responses were compared. The results of our study showed that the proportions of the innate lymphoid cell 1 group (ILC1) were similar in tonsil tissue in patients with recurrent tonsillitis and tonsil hypertrophy, with no statistically significant difference. It was observed that the innate lymphoid cell 2 group (ILC2) was the predominant group in tonsil hypertrophy, the innate lymphoid cell 3 group (ILC3) was the predominant innate lymphoid cell group in recurrent tonsillitis, and the proportion of IL-17 secreting T lymphocytes in blood and tonsillar mononuclear cells was higher in recurrent tonsillitis patients than in tonsil hypertrophy patients. With the results obtained, the predominant innate lymphoid cells in the pathogenesis of both diseases were identified and local and peripheral responses were compared. These findings may be a guide for possible medical treatments for both diseases in the future.

Identifiants

pubmed: 37742461
pii: S0165-5876(23)00307-5
doi: 10.1016/j.ijporl.2023.111740
pii:
doi:

Substances chimiques

Interleukin-17 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111740

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kerimcan Çakıcı (K)

Erciş Şehit Rıdvan Çevik State Hospital, Otolaryngology, Van, Turkey. Electronic address: kerim_cak@hotmail.com.

Ozan Gökdoğan (O)

Mugla Sitki Kocman University, Faculty of Medicine, Otolaryngology, Mugla, Turkey.

Deniz Genç (D)

Muğla Sıtkı Koçman University, Faculty of Health Sciences, Muğla, Turkey.

Burcu Günaydın (B)

Department of Histology & Embryology, Muğla Sıtkı Koçman University, Institute of Health Sciences, Muğla, Turkey.

Harun Üçüncü (H)

Mugla Sitki Kocman University, Faculty of Medicine, Otolaryngology, Mugla, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH